Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…
Drug Manufacturers - General
US, Indianapolis [HQ]
LLY/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21,836.00 | 23,076.00 | 24,286.00 | 22,603.00 | 23,113.00 | 19,615.00 | 19,958.00 | 21,222.00 | 22,871.00 | 21,493.00 | 22,319.00 | 24,539.00 | 28,318.00 | 28,541.00 | 34,124.00 | |
|
EPS
|
3.94 | 4.58 | 3.90 | 3.67 | 4.33 | 2.23 | 2.27 | 2.59 | -0.19 | 3.14 | 4.98 | 6.82 | 6.15 | 6.93 | 5.82 | |
| Diluted in mil. | 3.94 | 4.58 | 3.90 | 3.66 | 4.32 | 2.23 | 2.26 | 2.58 | -0.19 | 3.13 | 4.96 | 6.79 | 6.12 | 6.90 | 5.80 | |
|
Profit
|
17,589.00 | 18,709.00 | 19,218.00 | 17,806.00 | 18,205.00 | 14,683.00 | 14,921.00 | 15,567.00 | 16,801.00 | 16,811.00 | 17,598.00 | 19,056.00 | 21,005.00 | 21,911.00 | 27,548.00 | |
| Gross Margin | 80.55 | 81.08 | 79.13 | 78.78 | 78.76 | 74.85 | 74.76 | 73.35 | 73.46 | 78.22 | 78.85 | 77.66 | 74.18 | 76.77 | 80.73 | |
| Pre Tax | 5,357.00 | 6,525.00 | 5,349.00 | 5,408.00 | 5,889.00 | 3,000.00 | 2,790.00 | 3,374.00 | 2,197.00 | 3,680.00 | 5,265.00 | 7,229.00 | 6,155.00 | 6,806.00 | 6,554.00 | |
| Profit Margin | 24.54 | 28.28 | 22.03 | 23.93 | 25.48 | 15.30 | 13.98 | 15.90 | 9.61 | 17.12 | 23.59 | 29.46 | 21.74 | 23.85 | 19.21 | |
| ETR | 19.21 | 22.31 | 18.73 | 24.40 | 20.45 | 20.32 | 13.68 | 18.86 | 109.29 | 14.39 | 11.93 | 14.33 | 9.32 | 8.25 | 20.05 | |
| Net | 4,328.00 | 5,069.00 | 4,347.00 | 4,088.00 | 4,684.00 | 2,390.00 | 2,408.00 | 2,737.00 | -204.00 | 3,232.00 | 4,637.00 | 6,193.00 | 5,581.00 | 6,244.00 | 5,240.00 | |
| Profit Margin | 19.82 | 21.97 | 17.90 | 18.09 | 20.27 | 12.19 | 12.07 | 12.90 | -0.89 | 15.04 | 20.78 | 25.24 | 19.71 | 21.88 | 15.36 | |
| EBITDA | 7,743.00 | 8,152.00 | 7,180.00 | 4,508.00 | 5,230.00 | 3,997.00 | 4,494.00 | 4,283.00 | 7,717.00 | 9,645.00 | 6,604.00 | 7,641.00 | 8,739.00 | 9,433.00 | 12,455.00 | |
| EBITDA Margin | 35.46 | 35.33 | 29.56 | 19.95 | 22.63 | 20.38 | 22.52 | 20.19 | 33.74 | 44.87 | 29.59 | 31.14 | 30.86 | 33.05 | 36.50 | |
| Operating Income | 6,370.00 | 6,772.00 | 5,528.00 | 4,734.00 | 5,370.00 | 2,659.00 | 2,689.00 | 3,458.00 | 2,145.00 | 6,186.00 | 4,974.00 | 6,058.00 | 6,357.00 | 7,127.00 | 10,325.00 | |
| Operating Margin | 29.17 | 29.35 | 22.76 | 20.94 | 23.24 | 13.56 | 13.47 | 16.30 | 9.38 | 28.78 | 22.29 | 24.69 | 22.45 | 24.97 | 30.26 | |
| Interest Income | 75.00 | 51.00 | 79.00 | 105.00 | 119.00 | 121.00 | 87.00 | 108.00 | 167.00 | 161.00 | 80.00 | 33.00 | 25.00 | 62.00 | 173.00 | |
| Loss | -15,466.00 | -16,303.00 | -17,968.00 | -17,588.00 | -17,565.00 | -16,286.00 | -16,366.00 | -17,350.00 | -17,940.00 | -15,708.00 | -16,530.00 | -17,690.00 | -20,770.00 | -20,261.00 | -23,798.00 | |
| Cost of Revenue | -4,247.00 | -4,366.00 | -5,067.00 | -4,796.00 | -4,908.00 | -4,932.00 | -5,037.00 | -5,654.00 | -6,070.00 | -4,681.00 | -4,721.00 | -5,483.00 | -7,312.00 | -6,629.00 | -6,576.00 | |
|
Operating Expenses
|
-11,219.00 | -11,937.00 | -12,900.00 | -12,791.00 | -12,656.00 | -11,354.00 | -11,329.00 | -11,695.00 | -11,869.00 | -11,026.00 | -11,808.00 | -12,206.00 | -13,457.00 | -13,631.00 | -17,222.00 | |
| R&D | -4,326.00 | -4,884.00 | -5,020.00 | -5,278.00 | -5,531.00 | -4,733.00 | -4,796.00 | -5,243.00 | -5,281.00 | -5,051.00 | -5,595.00 | -6,085.00 | -7,025.00 | -7,190.00 | -9,313.00 | |
| G&A | -6,892.00 | -7,053.00 | -7,879.00 | -7,513.00 | -7,125.00 | -6,620.00 | -6,533.00 | -6,452.00 | -6,588.00 | -5,975.00 | -6,213.00 | -6,121.00 | -6,431.00 | -6,440.00 | -6,941.00 | |
| SG&A | -6,892.00 | -7,053.00 | -7,879.00 | -7,513.00 | -7,125.00 | -6,620.00 | -6,533.00 | -6,452.00 | -6,588.00 | -5,975.00 | -6,213.00 | -6,121.00 | -6,431.00 | -6,440.00 | -7,403.00 | |
| S&M | - - | - - | - - | -7,513.00 | -7,125.00 | -6,620.00 | -6,533.00 | -6,452.00 | -6,588.00 | -5,975.00 | -6,213.00 | -1,100.00 | -1,200.00 | -1,000.00 | -461.00 | |
| Depreciation and Amortization | -1,297.00 | -1,328.00 | -1,373.00 | -1,462.00 | -1,445.00 | -1,379.00 | -1,427.00 | -1,496.00 | -1,567.00 | -1,609.00 | -1,232.00 | -1,323.00 | -1,547.00 | -1,522.00 | -1,527.00 | |
| Interest Expenses | -261.00 | -185.00 | -186.00 | -177.00 | -160.00 | -148.00 | -161.00 | -185.00 | -225.00 | -272.00 | -400.00 | -359.00 | -339.00 | -331.00 | -312.00 | |
| Other Expenses | -826.00 | -113.00 | -862.00 | -465.00 | -381.00 | -300.00 | -727.00 | -420.00 | -2,676.00 | -2,105.00 | -291.00 | -1,171.00 | -201.00 | -320.00 | -3,770.00 | |
|
WA Shares Outstanding
|
1,098.00 | 1,105.00 | 1,113.00 | 1,113.00 | 1,080.00 | 1,069.00 | 1,061.00 | 1,058.00 | 1,052.00 | 1,027.00 | 931.00 | 907.00 | 906.00 | 901.00 | 900.00 | |
| Diluted | 1,098.00 | 1,105.00 | 1,113.00 | 1,117.00 | 1,084.00 | 1,074.00 | 1,065.00 | 1,061.00 | 1,052.00 | 1,033.00 | 935.00 | 912.00 | 911.00 | 904.00 | 903.00 |